Pharmaceutical composition containing irbesartan
AssigneeTeva Pharmaceuticals USA, Inc.
InventorsGershon Kolatkar, Erela Zisman
Life of this patent
Estimating the term…
Abstract
This invention relates to pharmaceutical compositions containing irbesartan, providing oral formulations with a high relative amount or concentration of irbesartan. In one embodiment, the present invention provides an oral formulation of irbesartan containing greater than 70% w/w irbesartan. In another embodiment, the invention provides an oral formulation of irbesartan which exhibits a dissolution profile according to which greater than about 85% of the Irbesartan is dissolved within about 30 minutes using USP apparatus 2, placing the tablet in 1000 mL of 0.1N hydrochloric acid at 37° C. with paddle speed of 50 rpm. The formulation can optionally contain at least one additional active ingredient.
Claims29
A composition comprising irbesartan, a binder, and a surfactant, wherein the irbesartan is greater than 70% w/w of the composition.
A composition comprising irbesartan, a binder, and a surfactant, wherein the irbesartan is at least 75% w/w of the composition.
Dependencies are inferred from the claim text.